Cellular Dynamics International CDI
Cellular Dynamics Announces Commercial Launch of iCell Cardiomyocytes for Drug Candidate Toxicity Screening
Published in Pharma Law Weekly, December 29th, 2009
Cellular Dynamics International (CDI) announced the commercial launch of iCell™ Cardiomyocytes for use in testing of new drug candidates by the pharmaceutical industry. These human heart cells are designed to aid drug discovery and improve the predictability of drug compound efficacy and toxicity screens, weeding out ineffective and potentially toxic compounds early in the pharmaceutical pipeline process before significant time and resources have been invested.
iCell Cardiomyocytes are derived from induced pluripotent stem (iPS) cells, spontaneously beat in vitro and exhibit the electrophysiological and biochemical properties of normal human heart cells. Thus,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly
Source: Pharma Law Weekly (2009-12-29)
More Articles from Pharma Law Weekly
- Abramowitz & Pomerantz, P.A.
Federal Court Verdict Upholds $5.75 Million Legal Settlements in Drowning of Jazz Musician and Rabbi's Wife off Miami Beach - Advocates for Highway and Auto Safety
Motorcoach Bus Safety Bill Wins U.S. Senate Committee Approval - America's Charities
Don Sodo Retires After 22 Years as President and CEO of America's Charities - American Association of Neurological Surgeons AANS and Congress of Neurological Surgeons CNS
State and National Medical Societies Join Forces to Oppose Senator Reid's Health Reform Bill - American Chemical Society
Toward reading your own personal 'Book of Life' - American Medical Informatics Association
Journal of the American Medical Informatics Association - More from this issue of Pharma Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
